与治疗相关的克隆血液形成的独特景观和临床影响
Koichi Takahashi1, Daisuke Nakada2, Margaret Goodell3
1Departments of Leukemia and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The Journal of clinical investigation
|October 1, 2024
概括
治疗相关的克隆性血液形成 (t-CH) 是一种影响癌症幸存者在化疗或放射治疗后的疾病. 研究探讨其独特的遗传原因和对患者的临床影响.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 克隆性血液形成 (CH) 在衰老中很常见,但与治疗相关的CH (t-CH) 特别影响癌症患者的治疗后.
- 在瘤学中增加的基因分析显示,t-CH在癌症幸存者中越来越多地被检测到.
- t-CH是由化疗/辐射引起的,导致明显的基因突变.
研究的目的:
- 审查推动t-CH发展的机制.
- 描述t-CH.的独特突变格局.
- 讨论t-CH在癌症患者中的临床影响和意义.
主要方法:
- 对与治疗相关的克隆性血液形成现有文献的综述.
- 分析与t-CH相关的遗传特征.
- 讨论与t-CH.相关的临床数据和结果.
主要成果:
- t-CH是由化疗/辐射驱动的,具有明显的突变特征.
- 关键的基因包括TP53,PPM1D和CHEK2,通常与DNA损伤反应有关.
- 与一般人群中CH相比,t-CH具有独特的临床影响.
结论:
- 在癌症患者中,t-CH是一种独特的实体,与一般人群中的CH不同.
- 了解t-CH机制和临床影响对于癌症治疗至关重要.
- 需要进一步的研究来缓解t-CH的出现和管理其后果.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


